BOBBI LEE ROTH: Open Payments
NPI 1558890848 · TUALATIN, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,134 in 226 payments from 32 companies in 2025. Trend: 2023 $4,456 · 2024 $8,642 · 2025 $5,134
Food & beverage: $5,119Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $478 |
| Biogen, Inc. | 31 | $446 |
| UCB, Inc. | 22 | $403 |
| Neurocrine BioSciences, Inc. | 11 | $362 |
| TG Therapeutics, Inc. | 6 | $320 |
| EMD Serono, Inc. | 8 | $289 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $248 |
| Lundbeck LLC | 12 | $247 |
| PFIZER INC. | 13 | $233 |
| SK Life Science, Inc. | 11 | $221 |
Products named: INGREZZA, TYSABRI, QULIPTA, BRIUMVI, REXULTI, HYQVIA, NURTEC ODT, Briviact.
Industry payments across OR — which companies pay providers there.
